Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 433

1.

Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider.

Unger J, Putrik P, Buttgereit F, Aletaha D, Bianchi G, Bijlsma JWJ, Boonen A, Cikes N, Dias JM, Falzon L, Finckh A, Gossec L, Kvien TK, Matteson EL, Sivera F, Stamm TA, Szekanecz Z, Wiek D, Zink A, Dejaco C, Ramiro S.

RMD Open. 2018 Dec 5;4(2):e000756. doi: 10.1136/rmdopen-2018-000756. eCollection 2018.

2.

EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology.

Dejaco C, Putrik P, Unger J, Aletaha D, Bianchi G, Bijlsma JW, Boonen A, Cikes N, Finckh A, Gossec L, Kvien TK, Madruga Dias J, Matteson EL, Sivera F, Stamm TA, Szekanecz Z, Wiek D, Zink A, Ramiro S, Buttgereit F.

RMD Open. 2018 Dec 5;4(2):e000780. doi: 10.1136/rmdopen-2018-000780. eCollection 2018.

3.

Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study.

Servioli L, Maciel G, Nannini C, Crowson CS, Matteson EL, Cornec D, Berti A.

J Rheumatol. 2019 Jan 15. pii: jrheum.180481. doi: 10.3899/jrheum.180481. [Epub ahead of print]

PMID:
30647188
4.

Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.

Zhang J, Wang D, Wang L, Wang S, Roden AC, Zhao H, Li X, Prakash YS, Matteson EL, Tschumperlin DJ, Vassallo R.

Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L487-L497. doi: 10.1152/ajplung.00301.2018. Epub 2019 Jan 3.

PMID:
30604628
5.

Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases.

Mira-Avendano I, Abril A, Burger CD, Dellaripa PF, Fischer A, Gotway MB, Lee AS, Lee JS, Matteson EL, Yi ES, Ryu JH.

Mayo Clin Proc. 2019 Feb;94(2):309-325. doi: 10.1016/j.mayocp.2018.09.002. Epub 2018 Dec 14. Review.

PMID:
30558827
6.

Longitudinal Occurrence and Predictors of Patient-Provider Discordance Between Global Assessments of Disease Activity in Rheumatoid Arthritis: A Case-Control Study.

Challa DNV, Kvrgic Z, Crowson CS, Matteson EL, Mason TG, Michet CJ Jr, Schaffer DE, Wright KA, Davis JM III.

Arthritis Care Res (Hoboken). 2018 Nov 30. doi: 10.1002/acr.23819. [Epub ahead of print]

PMID:
30506552
7.

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, González-Pérez MI, Mejía M, Buendía-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Lioté H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clément A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieudé P.

N Engl J Med. 2018 Dec 6;379(23):2209-2219. doi: 10.1056/NEJMoa1801562. Epub 2018 Oct 20.

PMID:
30345907
8.

Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort.

Berti A, Cornec-Le Gall E, Cornec D, Casal Moura M, Matteson EL, Crowson CS, Ravindran A, Sethi S, Fervenza FC, Specks U.

Nephrol Dial Transplant. 2018 Aug 8. doi: 10.1093/ndt/gfy250. [Epub ahead of print]

PMID:
30102330
9.

Prevention of glucocorticoid morbidity in giant cell arteritis.

Buttgereit F, Matteson EL, Dejaco C, Dasgupta B.

Rheumatology (Oxford). 2018 Feb 1;57(suppl_2):ii11-ii21. doi: 10.1093/rheumatology/kex459. Review.

PMID:
29982779
10.

Large-vessel giant cell arteritis: diagnosis, monitoring and management.

Koster MJ, Matteson EL, Warrington KJ.

Rheumatology (Oxford). 2018 Feb 1;57(suppl_2):ii32-ii42. doi: 10.1093/rheumatology/kex424. Review.

PMID:
29982778
11.

Hospitalization Increases the Risk of Acute Arthritic Flares in Gout: A Population-based Study over 2 Decades.

Zleik N, Elfishawi MM, Kvrgic Z, Michet CJ Jr, Crowson CS, Matteson EL, Bongartz T.

J Rheumatol. 2018 Aug;45(8):1188-1191. doi: 10.3899/jrheum.171320. Epub 2018 Jul 1.

PMID:
29961683
12.

Spontaneous Pneumomediastinum in Connective Tissue Diseases.

De Giacomi F, Baqir M, Cox CW, Moua T, Matteson EL, Ryu JH.

J Clin Rheumatol. 2018 Jun 18. doi: 10.1097/RHU.0000000000000835. [Epub ahead of print]

PMID:
29916965
13.

Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease.

Mango RL, Matteson EL, Crowson CS, Ryu JH, Makol A.

Lung. 2018 Aug;196(4):409-416. doi: 10.1007/s00408-018-0126-6. Epub 2018 May 21.

PMID:
29785507
14.

Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study.

Berti A, Matteson EL, Crowson CS, Specks U, Cornec D.

Mayo Clin Proc. 2018 May;93(5):597-606. doi: 10.1016/j.mayocp.2018.02.010. Epub 2018 Mar 24.

15.

Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013-supplementary presentation.

Ungprasert P, Crowson CS, Matteson EL.

Osteoporos Int. 2018 May;29(5):1201. doi: 10.1007/s00198-017-4074-4. Epub 2018 Mar 22.

PMID:
29569153
16.

Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).

van der Heijde D, Daikh DI, Betteridge N, Burmester GR, Hassett AL, Matteson EL, van Vollenhoven R, Lakhanpal S.

Arthritis Rheumatol. 2018 Jun;70(6):826-831. doi: 10.1002/art.40448. Epub 2018 Mar 13.

PMID:
29532625
17.

Hospitalisation rates among patients with primary Sjögren's syndrome: a population-based study, 1995-2016.

Maciel G, Servioli L, Nannini C, Berti A, Crowson CS, Achenbach SJ, Matteson EL, Cornec D.

RMD Open. 2018 Feb 28;4(1):e000575. doi: 10.1136/rmdopen-2017-000575. eCollection 2018.

18.

Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).

van der Heijde D, Daikh DI, Betteridge N, Burmester GR, Hassett AL, Matteson EL, van Vollenhoven R, Lakhanpal S.

Ann Rheum Dis. 2018 Jun;77(6):829-832. doi: 10.1136/annrheumdis-2017-212565. Epub 2018 Mar 13. Review.

PMID:
29525777
19.

Treatments for giant cell arteritis: Meta-analysis and assessment of estimates reliability using the fragility index.

Berti A, Cornec D, Medina Inojosa JR, Matteson EL, Murad MH.

Semin Arthritis Rheum. 2018 Aug;48(1):77-82. doi: 10.1016/j.semarthrit.2017.12.009. Epub 2018 Jan 6. Review.

PMID:
29496228
20.

Clinical Correlates, Outcomes, and Predictors of Inflammatory Ocular Disease Associated with Rheumatoid Arthritis in the Biologic Era.

Caimmi C, Crowson CS, Smith WM, Matteson EL, Makol A.

J Rheumatol. 2018 May;45(5):595-603. doi: 10.3899/jrheum.170437. Epub 2018 Feb 15.

PMID:
29449499
21.

Transcriptional Profiling of Synovial Macrophages Using Minimally Invasive Ultrasound-Guided Synovial Biopsies in Rheumatoid Arthritis.

Mandelin AM 2nd, Homan PJ, Shaffer AM, Cuda CM, Dominguez ST, Bacalao E, Carns M, Hinchcliff M, Lee J, Aren K, Thakrar A, Montgomery AB, Bridges SL Jr, Bathon JM, Atkinson JP, Fox DA, Matteson EL, Buckley CD, Pitzalis C, Parks D, Hughes LB, Geraldino-Pardilla L, Ike R, Phillips K, Wright K, Filer A, Kelly S, Ruderman EM, Morgan V, Abdala-Valencia H, Misharin AV, Budinger GS, Bartom ET, Pope RM, Perlman H, Winter DR.

Arthritis Rheumatol. 2018 Jun;70(6):841-854. doi: 10.1002/art.40453. Epub 2018 May 3.

PMID:
29439295
22.

Large-Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease?

Muratore F, Kermani TA, Crowson CS, Koster MJ, Matteson EL, Salvarani C, Warrington KJ.

Arthritis Care Res (Hoboken). 2018 Sep;70(9):1406-1411. doi: 10.1002/acr.23498. Epub 2018 Aug 12.

PMID:
29266882
23.

Orthopedic Surgery Among Patients With Rheumatoid Arthritis: A Population-Based Study to Identify Risk Factors, Sex Differences, and Time Trends.

Richter MD, Crowson CS, Matteson EL, Makol A.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1546-1550. doi: 10.1002/acr.23499. Epub 2018 Sep 7.

PMID:
29266862
24.

The Rising Incidence of Gout and the Increasing Burden of Comorbidities: A Population-based Study over 20 Years.

Elfishawi MM, Zleik N, Kvrgic Z, Michet CJ Jr, Crowson CS, Matteson EL, Bongartz T.

J Rheumatol. 2018 Apr;45(4):574-579. doi: 10.3899/jrheum.170806. Epub 2017 Dec 15.

PMID:
29247151
25.

Increased Risk of Multimorbidity in Patients With Sarcoidosis: A Population-Based Cohort Study 1976 to 2013.

Ungprasert P, Matteson EL, Crowson CS.

Mayo Clin Proc. 2017 Dec;92(12):1791-1799. doi: 10.1016/j.mayocp.2017.09.015. Epub 2017 Nov 3.

26.

Neurosarcoidosis.

Ungprasert P, Matteson EL.

Rheum Dis Clin North Am. 2017 Nov;43(4):593-606. doi: 10.1016/j.rdc.2017.06.008. Epub 2017 Aug 23. Review.

PMID:
29061245
27.

Clinical Characteristics of Ocular Sarcoidosis: A Population-Based Study 1976-2013.

Ungprasert P, Tooley AA, Crowson CS, Matteson EL, Smith WM.

Ocul Immunol Inflamm. 2017 Oct 12:1-7. doi: 10.1080/09273948.2017.1386791. [Epub ahead of print]

PMID:
29023165
28.

Accuracy of Diagnostic Coding for Sarcoidosis in Electronic Databases: A Population-Based Study.

Ungprasert P, Matteson EL, Crowson CS.

Lung. 2017 Dec;195(6):713-715. doi: 10.1007/s00408-017-0054-x. Epub 2017 Oct 9.

29.

Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis.

Alibaz-Oner F, Koster MJ, Unal AU, Yildirim HG, Çikikçi C, Schmidt J, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Direskeneli H, Warrington KJ.

Rheumatology (Oxford). 2017 Nov 1;56(11):1939-1944. doi: 10.1093/rheumatology/kex300.

PMID:
28968808
30.

Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study.

Raheel S, Matteson EL, Crowson CS, Myasoedova E.

Rheumatology (Oxford). 2017 Dec 1;56(12):2154-2161. doi: 10.1093/rheumatology/kex352.

31.

Comment on: Patterns of interstitial lung disease and mortality in rheumatoid arthritis: reply.

Matteson EL, Zamora-Legoff JA, Krause ML, Ryu JH, Crowson CS.

Rheumatology (Oxford). 2017 Oct 1;56(10):1825. doi: 10.1093/rheumatology/kex299. No abstract available.

PMID:
28957566
32.

Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study.

Ungprasert P, Crowson CS, Cartin-Ceba R, Garrity JA, Smith WM, Specks U, Matteson EL, Makol A.

Rheumatology (Oxford). 2017 Oct 1;56(10):1763-1770. doi: 10.1093/rheumatology/kex261.

33.

Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluation.

Challa DN, Kvrgic Z, Cheville AL, Crowson CS, Bongartz T, Mason TG 2nd, Matteson EL, Michet CJ Jr, Persellin ST, Schaffer DE, Muskardin TLW, Wright K, Davis JM 3rd.

Arthritis Res Ther. 2017 Sep 26;19(1):212. doi: 10.1186/s13075-017-1419-5.

34.

Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B.

Nat Rev Rheumatol. 2017 Oct;13(10):578-592. doi: 10.1038/nrrheum.2017.142. Epub 2017 Sep 14. Review.

35.

The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.

Berti A, Cornec D, Crowson CS, Specks U, Matteson EL.

Arthritis Rheumatol. 2017 Dec;69(12):2338-2350. doi: 10.1002/art.40313. Epub 2017 Nov 9.

36.

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.

Crowson CS, Rollefstad S, Ikdahl E, Kitas GD, van Riel PLCM, Gabriel SE, Matteson EL, Kvien TK, Douglas K, Sandoo A, Arts E, Wållberg-Jonsson S, Innala L, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon C, Ramos VP, Yáñez IC, Sfikakis PP, Zampeli E, Gonzalez-Gay MA, Corrales A, Laar MV, Vonkeman HE, Meek I, Semb AG; A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA).

Ann Rheum Dis. 2018 Jan;77(1):48-54. doi: 10.1136/annrheumdis-2017-211735. Epub 2017 Sep 6.

37.

Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976-2013.

Ungprasert P, Crowson CS, Simonetto DA, Matteson EL.

Am J Gastroenterol. 2017 Oct;112(10):1556-1563. doi: 10.1038/ajg.2017.231. Epub 2017 Sep 5.

38.

Polymyalgia rheumatica.

González-Gay MA, Matteson EL, Castañeda S.

Lancet. 2017 Oct 7;390(10103):1700-1712. doi: 10.1016/S0140-6736(17)31825-1. Epub 2017 Jul 31. Review.

PMID:
28774422
39.
40.

Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells.

Shen Y, Wen Z, Li Y, Matteson EL, Hong J, Goronzy JJ, Weyand CM.

Nat Immunol. 2017 Sep;18(9):1025-1034. doi: 10.1038/ni.3808. Epub 2017 Jul 24.

41.

Reliability of Cardiovascular Risk Calculators to Estimate Accurately the Risk of Cardiovascular Disease in Patients With Sarcoidosis.

Ungprasert P, Matteson EL, Crowson CS.

Am J Cardiol. 2017 Sep 1;120(5):868-873. doi: 10.1016/j.amjcard.2017.05.060. Epub 2017 Jun 15.

42.

Comparable Rates of Glucocorticoid-Associated Adverse Events in Patients With Polymyalgia Rheumatica and Comorbidities in the General Population.

Shbeeb I, Challah D, Raheel S, Crowson CS, Matteson EL.

Arthritis Care Res (Hoboken). 2018 Apr;70(4):643-647. doi: 10.1002/acr.23320. Epub 2018 Feb 22.

PMID:
28704600
43.

Opioid use in patients with polymyalgia rheumatica.

Richter MD, Achenbach SJ, Zamora-Legoff JA, Crowson CS, Matteson EL.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):1014-1017. Epub 2017 Jun 29.

44.

Post-9/11 sarcoidosis in WTC-exposed firefighters and emergency medical service workers.

Webber MP, Yip J, Zeig-Owens R, Moir W, Ungprasert P, Crowson CS, Hall CB, Jaber N, Weiden MD, Matteson EL, Prezant DJ.

Respir Med. 2017 Nov;132:232-237. doi: 10.1016/j.rmed.2017.06.004. Epub 2017 Jun 7.

45.

Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013.

Ungprasert P, Crowson CS, Matteson EL.

Neuroepidemiology. 2017;48(3-4):87-94. doi: 10.1159/000477300. Epub 2017 Jun 10.

46.

Response.

Ungprasert P, Crowson CS, Matteson EL.

Chest. 2017 Jun;151(6):1399. doi: 10.1016/j.chest.2017.03.021. No abstract available.

PMID:
28599935
47.

Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.

Crowson CS, Matteson EL.

Semin Arthritis Rheum. 2017 Oct;47(2):253-256. doi: 10.1016/j.semarthrit.2017.04.001. Epub 2017 Apr 7.

48.

Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.

Ungprasert P, Crowson CS, Matteson EL.

Reumatismo. 2017 May 22;69(1):16-22. doi: 10.4081/reumatismo.2017.965. Review.

49.

Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.

Wilton KM, Matteson EL.

Rheumatol Ther. 2017 Dec;4(2):333-347. doi: 10.1007/s40744-017-0064-4. Epub 2017 May 15. Review.

50.

Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics.

Corban MT, Duarte-Garcia A, McBane RD, Matteson EL, Lerman LO, Lerman A.

J Am Coll Cardiol. 2017 May 9;69(18):2317-2330. doi: 10.1016/j.jacc.2017.02.058. Review.

Supplemental Content

Loading ...
Support Center